Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Nicholas A Tritos, D.Sc., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Nicholas Tritos and Anne Klibanski.
Nicholas Tritos
Connection Strength
6.798
Anne Klibanski
  1. Tritos NA, Klibanski A. Effects of Growth Hormone on Bone. Prog Mol Biol Transl Sci. 2016; 138:193-211.
    View in: PubMed
    Score: 0.718
  2. Tritos NA, Klibanski A. Hyperprolactinemia. JAMA. 2015 Oct 27; 314(16):1742-3.
    View in: PubMed
    Score: 0.708
  3. Tritos NA, Eppakayala S, Swearingen B, Hedley-Whyte ET, Miller KK, Nachtigall LB, Grinspoon SK, Biller BM, Klibanski A. Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013 Sep; 16(3):287-93.
    View in: PubMed
    Score: 0.610
  4. Klibanski A, Schlechte J, Tritos N. Diabetes insipidus. J Clin Endocrinol Metab. 2013 Jul; 98(7):35A-36A.
    View in: PubMed
    Score: 0.603
  5. Tritos NA, Byrne TN, Wu CL, Klibanski A. A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening. Nat Rev Endocrinol. 2011 Jan; 7(1):54-9.
    View in: PubMed
    Score: 0.503
  6. Galm BP, Buckless C, Swearingen B, Torriani M, Klibanski A, Bredella MA, Tritos NA. MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands. Pituitary. 2020 Jun; 23(3):212-222.
    View in: PubMed
    Score: 0.243
  7. Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA. Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab. 2020 Jun 01; 105(6).
    View in: PubMed
    Score: 0.243
  8. Tritos NA, Mattsson AF, Vila G, Biller BMK, Klibanski A, Valluri S, Hey-Hadavi J, Kelepouris N, Jimenez C. All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur J Endocrinol. 2020 Mar; 182(3):285-292.
    View in: PubMed
    Score: 0.239
  9. Barake M, Klibanski A, Tritos NA. MANAGEMENT OF ENDOCRINE DISEASE: Impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry? Eur J Endocrinol. 2018 Dec 01; 179(6):R287-R296.
    View in: PubMed
    Score: 0.219
  10. Galm BP, Martinez-Salazar EL, Swearingen B, Torriani M, Klibanski A, Bredella MA, Tritos NA. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. Eur J Endocrinol. 2018 Sep; 179(3):191-198.
    View in: PubMed
    Score: 0.213
  11. Jahandideh D, Swearingen B, Nachtigall LB, Klibanski A, Biller BMK, Tritos NA. Characterization of cyclic Cushing's disease using late night salivary cortisol testing. Clin Endocrinol (Oxf). 2018 09; 89(3):336-345.
    View in: PubMed
    Score: 0.213
  12. Barake M, Arabi A, Nakhoul N, El-Hajj Fuleihan G, El Ghandour S, Klibanski A, Tritos NA. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine. 2018 01; 59(1):39-49.
    View in: PubMed
    Score: 0.203
  13. Silva PPB, Amlashi FG, Yu EW, Pulaski-Liebert KJ, Gerweck AV, Fazeli PK, Lawson E, Nachtigall LB, Biller BMK, Miller KK, Klibanski A, Bouxsein M, Tritos NA. Bone microarchitecture and estimated bone strength in men with active acromegaly. Eur J Endocrinol. 2017 Nov; 177(5):409-420.
    View in: PubMed
    Score: 0.200
  14. Tritos NA, Chanson P, Jimenez C, King D, Jönsson PJ, Klibanski A, Biller BM. Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. Eur J Endocrinol. 2017 Feb; 176(2):213-220.
    View in: PubMed
    Score: 0.190
  15. Faje A, Tritos NA, Swearingen B, Klibanski A. Neuroendocrine disorders: pituitary imaging. Handb Clin Neurol. 2016; 136:873-85.
    View in: PubMed
    Score: 0.179
  16. Silva PP, Bhatnagar S, Herman SD, Zafonte R, Klibanski A, Miller KK, Tritos NA. Predictors of Hypopituitarism in Patients with Traumatic Brain Injury. J Neurotrauma. 2015 Nov 15; 32(22):1789-95.
    View in: PubMed
    Score: 0.176
  17. Amlashi FG, Swearingen B, Faje AT, Nachtigall LB, Miller KK, Klibanski A, Biller BM, Tritos NA. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. J Clin Endocrinol Metab. 2015 Oct; 100(10):3770-7.
    View in: PubMed
    Score: 0.174
  18. Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab. 2014 Jun; 99(6):2018-29.
    View in: PubMed
    Score: 0.159
  19. Barake M, Evins AE, Stoeckel L, Pachas GN, Nachtigall LB, Miller KK, Biller BM, Tritos NA, Klibanski A. Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary. 2014 Apr; 17(2):150-6.
    View in: PubMed
    Score: 0.159
  20. Barake M, Klibanski A, Tritos NA. Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab. 2014 Mar; 99(3):852-60.
    View in: PubMed
    Score: 0.156
  21. Hypopituitarism. J Clin Endocrinol Metab. 2013 Nov; 98(11):43A-44A.
    View in: PubMed
    Score: 0.154
  22. Bollerslev J, Klibanski A, Tritos N. Traumatic brain injury: effects on the endocrine system. J Clin Endocrinol Metab. 2013 Mar; 98(3):27A-8A.
    View in: PubMed
    Score: 0.147
  23. Sanchez-Ortiga R, Klibanski A, Tritos NA. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf). 2012 Jul; 77(1):86-93.
    View in: PubMed
    Score: 0.141
  24. Khairi S, Sagvand BT, Pulaski-Liebert KJ, Tritos NA, Klibanski A, Nachtigall LB. CLINICAL OUTCOMES AND SELF-REPORTED SYMPTOMS IN PATIENTS WITH ACROMEGALY: AN 8-YEAR FOLLOW-UP OF A LANREOTIDE STUDY. Endocr Pract. 2017 Jan; 23(1):56-65.
    View in: PubMed
    Score: 0.047
  25. Sagvand BT, Khairi S, Haghshenas A, Swearingen B, Tritos NA, Miller KK, Klibanski A, Nachtigall LB. Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center. Pituitary. 2016 Aug; 19(4):437-47.
    View in: PubMed
    Score: 0.047
  26. Ajmal A, Haghshenas A, Attarian S, Barake M, Tritos NA, Klibanski A, Miller KK, Nachtigall LB. The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary. 2014 Aug; 17(4):366-73.
    View in: PubMed
    Score: 0.041
  27. Faje AT, Sullivan R, Lawrence D, Tritos NA, Fadden R, Klibanski A, Nachtigall L. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014 Nov; 99(11):4078-85.
    View in: PubMed
    Score: 0.041
  28. Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, Loeffler J, Biller BM, Klibanski A, Miller KK. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf). 2012 Sep; 77(3):430-8.
    View in: PubMed
    Score: 0.036
  29. Sheth SA, Mian MK, Neal J, Tritos NA, Nachtigall L, Klibanski A, Biller BM, Swearingen B. Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery. 2012 Jul; 71(1):14-22.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2020 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.